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The disease dengue (DEN) is caused by four serologically related viruses termed DEN1, DEN2, DEN3 and DEN4. The structure of the
ectodomain of the envelope protein has been determined previously for DEN2 and DEN3 viruses. Using NMR spectroscopic methods, we solved
the solution structure of domain III (ED3), the receptor-binding domain, of the envelope protein of DEN4 virus, human strain 703-4. The structure
shows that the nine amino acid changes in ED3 that separate the sylvatic and human DEN4 strains are surface exposed. Important structural
differences between DEN4-rED3 and ED3 domains of DEN2, DEN3 and other flaviviruses are discussed.
© 2007 Elsevier Inc. All rights reserved.Keywords: Flavivirus; Dengue; Dengue-4 virus; Envelope protein domain III; Nuclear magnetic resonance; StructureIntroduction
The flaviviruses (family Falviviridae, genus Flavivirus) are
typically transmitted by either mosquitoes or ticks and include
major human pathogens such as dengue (DEN), West Nile
(WN), yellow fever (YF), Japanese encephalitis (JE) and tick-
borne encephalitis (TBE) viruses. The disease DEN is the most
important arthropod-borne viral disease causing 50–100 million
cases of DEN fever each year and is transmitted between
humans by the mosquito Aedes aegypti. Since there are no
vaccines or antiviral agents to prevent DEN, there is great
interest in developing strategies to control this disease. Dengue
is caused by four serologically and genetically distinct viruses⁎ Corresponding author. Department of Biochemistry and Molecular Biology,
University of Texas Medical Branch, Galveston, TX 77555-1157, USA. Fax: +1
409 747 6850.
E-mail address: dggorens@utmb.edu (D.G. Gorenstein).
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doi:10.1016/j.virol.2007.02.023termed DEN1, DEN2, DEN3 and DEN4. Phylogenetic studies
show that DEN4 is the oldest of the four DEN viruses, and
human dengue viruses have evolved from sylvatic progenitors
that are maintained in nature in a mosquito-monkey transmis-
sion cycle (Wang et al., 2000). Surprisingly, only nine amino
acid mutations in ED3 separate the two most divergent DEN4
strains: sylvatic P65-215 and human 703-4. Of these nine
changes, six have been implicated in the emergence of the
human DEN4 virus (Wang et al., 2000; Twiddy et al., 2002).
Located on the surface of the virion, the flavivirus envelope
(E) protein represents the primary immunogen and plays a
central role in receptor binding and membrane fusion (Heinz
and Allison, 2000, 2001, 2003). Three distinct domains
(domains I, II and III or ED1, ED2 and ED3) have been
identified in the N-terminal 400 amino acids of the E-protein
both by immunological methods (Mandl et al., 1989; Crill and
Roehrig, 2001; Roehrig, 2003) and by X-ray crystallographic
studies of the dimeric extra-membrane portion of the E-proteins
148 D.E. Volk et al. / Virology 364 (2007) 147–154from Central European TBEV (Rey et al., 1995), DEN2 (Modis
et al., 2003), DEN3 (Modis et al., 2005) and WN (Kanai et al.,
2006; Nybakken et al., 2006) viruses. NMR-derived solution
structures of the JE (Wu et al., 2003), WN (Volk et al., 2004),
Omsk hemorrhagic fever (OHF) virus (Volk et al., 2006a,
2006b) and Langat (LGT) virus (Mukherjee et al., 2006) ED3
illustrate an overall similar structural fold for these flaviviruses.
Cryoelectron microscopic reconstructions of several mosquito-
borne flaviviruses indicate that the E-protein is arranged as
dimers on the virion surface, such that ED3 projects slightly
above the viral surface (Kuhn et al., 2002; Mukhopadhyay et al.,
2003). Interactions between five ED3 subunits at the virion 5-
fold axes of symmetry form pores on the virion surface to which
antibodies or receptors may bind. After cell binding and
endosomal encapsulation, a low pH-induced structural change
exposes the viral fusion peptide in ED2, after which the virus
and endosome fuse and viral RNA is released into the cell
cytoplasm (Modis et al., 2004).Fig. 1. (A) Two orthogonal views of the NMR-derived DEN4-rED3 backbone atom st
disulfide bond between C14 and C45 is shown in green. (B) Two orthogonal side-v
residues which differ between the two most divergent human (703-4) and sylvatic (The objective of this study was to determine the structural
characteristics of the DEN4-rED3 that may be related to
antigenic differences between DEN virus types and potential
host cell interactions (i.e., sylvatic DEN vs. human DEN).
ED3 has been reported to be the receptor-binding domain of
the virus (Hung et al., 2004; Chu et al., 2005), leading to the
hypothesis that variations in the structure and surface
chemistry of ED3 between different flaviviruses may affect
host cell receptor interactions and may play a role in variations
in viral pathogenesis.
Results
Quality of the NMR structures
The 15 final structures in the ensemble (Fig. 1) had low
molecular and restraints energy penalties. The structure
presented here is well defined, as shown by the r.m.s.d. valuesructures. Beta sheets 1–3 are colored cyan, orange and blue, respectively, and the
iews of a ribbon diagram of the Den4-rED3 NMR structure. The side chains of
P75-215) strains of DEN4-rED3 are shown as sticks.
Fig. 2. Western blot of recombinant DEN1, DEN3, DEN4 and West Nile virus
ED3s using Mab MDVP-55A at 0.67 μg/ml.
149D.E. Volk et al. / Virology 364 (2007) 147–154and restraint violations listed in Table 1. The final structures had
27±4 distance restraint violations over 0.3 Å, 3±1 violations
over 0.5 Å and 3±1 dihedral angle violations over 20° (Table 1).
Thus, 99.8% of the NOE restraints fit the structures determined.
The violations occur because the NOE interactions and cut-off
distances were set in an automated fashion into one of five
distance bins based on cross-peak volumes, disregarding
confounding effects such as amide proton exchange rates,
equivalent geminal groups and differing spin–spin relaxation
rates. One could move borderline peak volumes into less
restrictive distance bins to remove these violations. Likewise, the
dihedral angle restraints based either on chemical shift or HNHA
data overlap in angle space to a varying degree. The r.m.s.d. on
the distance restraint error was 0.018±0.001 Å, and the r.m.s.d.
on dihedral angle error was 0.27±0.05°. The structural ensemble
has a global backbone atom r.m.s.d. of 0.75±0.14 Å and a global
heavy atom r.m.s.d. of 1.08±0.17 Å. Residues 296–393 also
have low backbone atom r.m.s.d values, 1.19 and 1.42 Å,
respectively, compared to the DEN2 (Modis et al., 2003) and
DEN3 (Modis et al., 2005) virus E-protein X-ray structures.
The program PROCHECK (Laskowski et al., 1996) was
used to analyze the quality of the final ensemble. Analysis of the
non-glycine, non-proline residues indicated that 97.0% of the
residues are in the two most favored regions of a Ramachandran
plot. Specifically, 73.6% of the residues are in the most favored
regions, 23.4% of the residues are in the additionally allowedTable 1
Summary of NMR structure constraints and statistics
Total restraints 2071
NOE restraints 1419
Intra-residue 469
Sequential 385
Medium range 95
Long range 470
Talos phi/psi dihedral restraints 160
HNHA phi dihedral restraints 51
H-bond restraints 46
Omega dihedral restraints 111
Chirality restraints 284
Structural statistics
NOE violations >0.5 Å 3±1
NOE violations >0.3 Å 27±4
Dihedral angle violation >20° 3±1
Dihedral angle violation >10° 14±3
r.m.s.d from ideal geometry
Bond lengths (Å) 0.013
Bond angles (°) 2.3
Restraint error r.m.s.d.
Distance restraints (Å) 0.036±0.001
Dihedral restraints (°) 1.15±0.06
Atomic r.m.s.d.
Backbone atoms 0.75±0.14
All heavy atoms 1.08±0.17
Ramachandran statistics
Most favored regions (%) 73.6
Additionally allowed regions (%) 23.4
Generously allowed regions (%) 2.0
Disallowed regions (%) 1.0region, 2.0% of the residues are in the generously allowed
regions and 1.0% of the residues are in the disallowed regions.
Structural details of the NMR ensemble
The protein structure consists of three β-sheets arranged in a
β-barrel configuration (Fig. 1B). The first beta sheet, whose
upper, outer face is exposed in the viral particle, consists of β
strands β1, β2, β5 and β7 at residue positions F306-E314 (β1,
with a bulge at 309–312), T320-Y326 (β2), R350-I351 (β5)
and V365-E370 (β7). In an E-protein dimer, nearly half of this
beta sheet interacts with ED2 of the opposing protein monomer.
The small second beta sheet consists of beta strands β3 and β6
at residue positions C333-K334 (β3) and L357-A358 (β6). The
outer face of this beta sheet faces ED1 of the same E-protein
(Modis et al., 2003, 2005). The third beta sheet consists of beta
strands β4, β8 and β9 positioned at residues F337-R340, D375-
I380 (β8) and L387-F392 (β9). This beta sheet is the farthest
from the virion particle surface. All three beta sheets are also
present in the DEN2 and DEN3 ED3 protein structures;
however, β5 differs among the viruses. In both the DEN3
(R348-L349) and DEN4 (R350-I351) viruses, β5 is only two
amino acids long, while in the DEN2 virus, the twisted β5
strand (V347-L351) contains of an addition three amino acids
on the N-terminal side. This region of the flavivirus ED3 shows
considerable variation.
Binding of DEN complex monoclonal antibodies to ED3
Although epitopes in ED3 are primarily virus type or subtype
specific, many studies have identified monoclonal antibodies
(MAbs) that are DEN complex specific (i.e., recognize the E-
protein of DEN1, DEN2, DEN3 and DEN4 viruses only). We
examined the binding of two commercially available DEN
complex-reactive MAbs, GTX29202 and MDVP-55A (see
Materials and methods), that both recognized ED3 by Western
blot (Fig. 2). Since the structural data suggested that there are
distinct differences among the structure and surface chemistry of
ED3 for DEN2, DEN3 and DEN4 viruses, we examined theTable 2
Dissociation constants (Kd) of DEN complex MAbs with DEN1, DEN2, DEN3
and DEN4 rED3
MAb DEN1 DEN2 DEN3 DEN4
GTX29202 0.08±0.00 nM 0.21±0.01 nM 8.0±1.1 nM >3.0 μM
MDVP-55A 0.06±0.00 nM 0.23±0.02 nM 6.1±1.1 nM >3.0 μM
Fig. 3. Sequence alignment of flavivirus ED3 sequences. Beta sheet secondary structure is indicated by underlined bold characters.
150 D.E. Volk et al. / Virology 364 (2007) 147–154binding of these twoDEN complexMAbs to rED3s representing
all four DEN virus types. The twoMAbs bound tightly to DEN1
rED3 (Kd=0.06–0.08 nM) and DEN2 rED3 (Kd=0.2 nM), less
tightly to DEN3 rED3 (6–8 nM) and very poorly to DEN4 rED3
(>3 μM) (Table 2).
Discussion
The solution structure of the DEN4-rED3 reported here
represents the first NMR structure of a DEN virus-encoded
protein subunit. The overall structure is similar to those of theFig. 4. Ribbon diagrams of several flavivirus ED3 proteins illustrating their backbone
β5b (sometimes present) are shown in cyan while the same region is colored orangDEN2 and DEN3 ED3 structures obtained by X-ray crystal-
lography (Modis et al., 2003, 2005) as well as those of related
flaviviruses. Although the flavivirus ED3s share only 40–60%
amino acid homology as a group, nine beta strands are regularly
found in these proteins (Fig. 3). Beta strands one through four
are nearly identical in all of the flavivirus structures, although
β3 was not observed in the NMR structures of the JE and WN
viruses, both members of the JE serocomplex. Beta strands β8
and β9 are nearly consistent across all of the structures,
although they are both slightly longer in both the WN NMR and
X-ray determined structures.structural differences near beta strand five. Beta strands β5a (always present) and
e when beta sheets are not present.
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β6 and β7 (Figs. 3 and 4). With the exception of the JE and
LGT NMR structures, all of the ED3 structures contain a two-
residue beta strand (β5b). In DEN2 ED3, this beta strand is
extended on the N-terminal side by an additional three amino
acids (β5a), connected with a significant twist. This extension
of the beta sheet is not observed in the DEN3 crystal structure or
in the majority (of each NMR ensemble) of the flavivirus NMR
structures deposited. However, it should be noted that this, or a
similar extension, is observed in one (WN, OHF) to five (LGT)
of the NMR structures of each ensemble. In the WN and TBE
X-ray structures, beta strand β5a is longer and is separated from
strand β5b by one or two residues. Strand β6 in ED3 is likewise
variable among the flaviviruses. This strand is observed in all E-
protein structures for DEN viruses and in the tick-borne TBE,
LGT and OHF structures determined by NMR or X-ray crystal-
lography. However, it is not observed in the JE serocomplex
virus ED3 structures (JE and WN) determined by X-ray
(Nybakken et al., 2006) or NMR (Volk et al., 2004; Wu et al.,
2003) methods. Finally, although strand β7 is nearly consistent
among the mosquito-borne viruses, it is slightly shorter in all of
the tick-borne virus structures (TBE, OHF and LGT).
Inspection of the structures indicates that the variable beta
strands 5–7 all reside on one side of the ED3 (Fig. 1). In the
dimeric E-protein structure, this side interacts with domain ED1
of the same monomer unit. As a whole, the flavivirus structural
data suggest that this region of the protein is more variable and
dynamic than the rest of the ED3. Indeed, strand β6 is missing
in both the NMR and X-ray structures of WN ED3 as well as inFig. 5. Electrostatic exposed surface of ED3. Blue indicates positive charge while red
DEN4 viruses as viewed from within the 5-fold virion pore. The virion surface is loca
DEN4 ED3 proteins as viewed from above the virion surface.the JE structure, as is the neighboring strand β3 (Nybakken et
al., 2005; Volk et al., 2004; Wu et al., 2003). The observation
that the beta strands are present in a small number of models in
each NMR ensemble is consistent with a more dynamic protein
region, although relaxation measurements have only been
reported for the Langat virus ED3, which also support this idea
(Mukherjee et al., 2006). The extra length of strand β5 (β5a) in
the DEN2, WN and TBE X-ray structures (Fig. 4) compared to
DEN3 is also consistent with this interpretation. While this
region is expected to be more dynamic in an NMR structure in
which the isolated ED3 protein is used, the DEN3 structure is
based on the intact E-protein in a dimeric context. Thus, the
stability of this region (loop or β5a) appears to be highly
dependent on the crystal or solution conditions under which the
data were collected.
Although the four DEN viruses share a common name, they
are in fact serologically and genetically distinct viruses (Calisher
et al., 1989; Twiddy et al., 2003). Despite the similarity of the
flavivirus ED3 secondary structures and overall fold, each virus
displays a unique surface to which cell receptors or antibodies
might bind (Fig. 5). Very importantly, the electrostatic surfaces
of the DEN2, DEN3 and DEN4 ED3 proteins, as viewed from
the center of the virion 5-fold pore (Figs. 5A–C), clearly show
dramatic surface differences among these viruses. DEN2 has
significantly more negative charges near the bottom of the ED3
protein compared to DEN3 and DEN4, while DEN3 displays
significantly more negative charge near the upper surface of the
ED3 protein. In contrast, the distinguishing feature of the DEN4
is the greater amount of uncharged surface area relative to theindicates negative charge. (A–C) Electrostatic surface of the DEN2, DEN3 and
ted at the top of these images. (D–F) Electrostatic view of the DEN2, DEN3 and
152 D.E. Volk et al. / Virology 364 (2007) 147–154other two viruses. When viewed from above the virion surface
(Figs. 5D–F), the exposed surfaces again show distinct patterns.
The top of the DEN2 ED3 surface contains a mix of positive and
negative charges, while the DEN3 viral surface has a dominant
negative area. The DEN4 virus ED3 is notable for its mostly
neutral upper binding surface.
Studies with several flaviviruses have shown that ED3
encodes the major virus-specific neutralization site, which
consists of overlapping epitopes. Although there have been no
studies of neutralizing ED3 epitopes for DEN4 virus, examina-
tion of DEN2 ED3 protein with neutralizing virus type-specific
MAbs indicates that these antibodies interact primarily with
residues in the surface-exposed loops of ED3 protein and that
the specificity of their epitopes is associated with variations in
charge or hydrophobicity of the surface of ED3 protein (Lin et
al., 1994; Hiramatsu et al., 1996; Lok et al., 2001; Gromowski
et al., in preparation). Given the differences in electrostatic
charge on the surfaces of ED3 of DEN2, DEN3 and DEN4
viruses, it was predicted that these are important determinants of
differences in antigenicity and other biological properties of
these viruses. The differences in DEN ED3 antigenicity were
confirmed here by examining the binding of two DEN complex-
reactive MAbs to DEN1, DEN2, DEN3 and DEN4 rED3
proteins. Both MAbs had great differences in Kd values when
the four DEN rED3s were compared (Table 2) demonstrating
that, although there is some degree of antigenic conservation
between ED3 of DEN virus types, even “conserved” epitopes in
DEN ED3 differ significantly in their recognition by complex
reactive MAbs. Furthermore, Western blotting of DEN1, DEN3
and DEN4 rED3s with MAb MDVP-55A confirmed that this
MAb recognized all three ED3s, including a weak reaction with
DEN4 rED3 that is consistent with the physical binding data
(Table 2).
It has also been hypothesized that DEN viruses originally
existed in a sylvatic cycle involving mosquitoes and monkeys,
in the absence of human disease, but evolved into a human virus
causing disease with a cycle involving humans and Aedes
aegypti mosquitoes. Comparison of the E-proteins of human
isolate 703-4 with sylvatic isolate P75-215 reveals that there are
9 amino acid differences in ED3, of which 5 (K340R, M342V,
I335T, I364V and A382V) have been implicated from
phylogenetic studies (Wang et al., 2000) in the emergence of
DEN4 from a sylvatic virus to a human virus. Examination of
DEN4 ED3 protein structure presented here reveals that
although all five residues are conservative changes, they are
surface exposed suggesting that the emergence of human DEN
may have been in part due to changes in cell receptor-binding
properties of ED3.
Materials and methods
Protein expression and purification
Uniformly 15N-labeled, 15N,13C-labeled and unlabeled human
DEN4-rED3 proteins (strain 704-3, GenBank AAF61130, UNP
Q9IZI6) encompassing residues M289-K400 were expressed
using the pET-15 vector (Novagen), but lacking the N-terminalHis-tag sequence encoded in that plasmid. To avoid aggrega-
tion, the crude cell debris was first denatured using 8 M urea.
Urea was then removed by dialysis (3×1/2000 dilution). The
expressed proteins were purified over a Sephadex Q-column
and were subsequently filtered through an Amicon centrifugal
concentrator with a 30-kDa molecular weight cut-off to remove
proteins with higher molecular weights. Centricon concentra-
tors with a 3-kDa cut-off were used for the final concentration
step and to remove low-molecular weight impurities as well as
to exchange the material into the final NMR buffer.
NMR spectroscopy and the generation of NMR restraints
The NMR samples contained 0.6 mM protein in 50 mM
deuterated Tris (pH 7.5) and 50 mMNaCl in 90% H2O and 10%
D2O or 100% D2O. All experiments were acquired on Varian
UnityPlus 600 or Varian Inova 750 or 800 MHz spectrometers
equipped with Direct Drive architecture at 25 °C. Sequence-
specific chemical shifts (Volk et al., 2006a) for the backbone
resonances were obtained from three-dimensional HNHA
(Vuister and Bax, 1992), HNCA (Kay et al., 1992), HNCOCA
(Kay et al., 1992), HNCACB (Sattler et al., 1999), CBCA-
CONH (Grzesiek and Bax, 1992), HNCO (Ikura et al., 1990)
and HCACOCANH (Lohr and Ruterjans, 1995) experiments.
The backbone assignments were verified by sequential NOE
connectivities observed in an 15N-edited HSQC-NOESY
experiment (Marion et al., 1989) with a 150-ms mixing time
acquired at 750 MHz. Side chain assignments were derived
from HCCH-TOCSY (Vuister and Bax, 1992), 15N-edited
TOCSY (Kay et al., 1992), H(CCO)NH-TOCSY (Clore and
Gronenborn, 1994) and CC(CO)NH-TOCSY (Clore and
Gronenborn, 1994) experiments. Aromatic proton chemical
shifts were assigned from resonances in a CT-1H, 13C-HSQC
(John et al., 1993) spectrum, NOE spectra, HCBCGCDHD
(Yamazaki et al., 1993), HCBCGCDCDHE (Yamazaki et al.,
1993) and an HCCH-TOCSY (Bax et al., 1990) experiment
centered on the aromatic carbon region. Stereo-specific assign-
ments for some of the side-chain protons were obtained after
initial rounds of structure calculations using unambiguous
restraints. All spectra were processed with VNMR v6.1b
(Varian, Inc.) or Felix2000 (Accelrys, Inc.) software.
SANE (Duggan et al., 2001) was used to facilitate the
assignment of the 2D and 15N-edited NOE cross-peaks and for
the generation of restraints. Chemical shifts, distance cut-offs
and contribution cut-offs were used within the program. The
NMR restraints were separated into five bins, based on the
NOESY cross-peak volumes from which they were derived,
with upper distance limits of 2.5, 3.0, 4.0, 5.0 and 6.0 Å. The
1419 NOE-based restraints (see Table 1) consist of 469 intra-
residue, 385 sequential, 95 medium-range and 470 long-range
distance restraints.
TALOS (Cornilescu et al., 1999) was used to derive
160 phi/psi dihedral angle restraints based on the chemical shifts
of the amino acids. An additional 51 phi angle restraints were
derived from an HNHA experiment. Fifty-one hydrogen bond
restraints were added based on the structures obtained in the
initial structure calculations and strong peaks.
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One hundred random structures were generated by anneal-
ing the protein at 700 K, obtaining the coordinates every 5 ps
and minimizing the structures obtained. The structures were
then subjected to r-MD using dihedral angle restraints (Table
1) followed by the application of all restraints at 300 K.
Finally, the structures were energy minimized for 5,000 steps.
Fifteen structures with low restraint penalties were then chosen
for the structural ensemble. The SANDER module within
AMBER6.0 (Case et al., 1999) was used for all NMR structure
calculations, and MIDAS (Ferrin et al., 1988) and MOLMOL
(Koradi et al., 1996) were used to visualize the structures.
Coordinates for the ensemble of NMR structures of Den4-
rED3 have been deposited with the Protein Data Bank (PDB
ID 2H0P) and the chemical shifts (Volk et al., 2006a) have
been deposited with the BioMagResBank (accession code
7087).
Affinity measurements by indirect ELISA
The DEN complex Mabs GTX29202 (GeneTex, Inc.) and
MDVP-55A (Immunology Consultants Laboratory, Inc.),
which react with ED3 of DEN viruses 1–4, were tested for
their affinity to recombinant, MBP-tagged ED3s (rED3) for
DEN1 strain OBS7690, DEN2 strain 16681, DEN3 strain H87
and DEN4 strain 703-4. The wells of 96-well microtiter plates
(Corning Inc., Corning, NY) were coated with 200 ng of rED3
diluted in borate saline pH 9.0 at 37 °C for 2 h. This amount of
rED3 was determined to saturate the wells by using anti-MBP
antisera (NEB) (data not shown). Wells were washed twice with
purified water and blocked for 30 min at room temperature
(25 °C) with blocking buffer [phosphate-buffered saline (PBS),
0.1% (v/v) Tween-20, 0.25% (w/v) bovine serum albumin
(BSA)] and subsequently washed twice with purified water.
Both MAbs were diluted to either 5 nM, 40 nM, 400 nM or
3800 nM concentrations for affinity determination with DEN-1,
-2, -3 and -4 rED3s, respectively. These MAb dilutions were
added to duplicate wells followed by 11 two-fold serial dilutions
in blocking buffer. The MAb concentrations used were
determined to cover the full range of binding, from undetectable
binding to saturation, for each DEN rED3 except DEN-4 in
which case the full range of binding could not be achieved.
MAbs were allowed to bind overnight at room temperature
(25 °C) for 15–18 h. Subsequently, the microtiter plates were
washed twice with purified water and twice with PBS-T (PBS
containing 0.1% Tween-20) followed by addition of a 1/1000
dilution of HRP conjugated goat anti-mouse-immunoglobulins
(Sigma) and incubated for 1 h at room temperature. Following
this incubation microtiter plates were washed twice with
purified water and twice with PBS-T. Antibody binding was
visualized by addition of 3, 3′, 5, 5′-tetramethylbenzidene
substrate (Sigma). After 30 min of incubation at room
temperature the absorbance was read at 655 nm on a model
3550-UV plate reader (Bio-Rad, Hercules, CA). Binding curves
and Kd values were determined using SigmaPlot (SPSS Inc.,
Chicago, IL).Acknowledgments
This work was supported by grants U90CCU618754 from the
Centers for Disease Control, a grant from the Pediatric Dengue
Vaccine Initiative, U01 AI054827 from NIAID, H1296 from the
Welch Foundation, P42296LS0000 from the Defense Advanced
Research Projects Agency, DAAD17-01-D-0001 from the
Defense Threat Reduction Agency, 004952-0038-2003 from
the State of Texas Advanced Technology Program, fellowships
from the James W. McLaughlin Fellowship Fund to D.W.C.B.,
and T32 AI 07526 to G.D.G.
The atomic coordinates of theNMR solution structure (2H0P)
have been deposited with the Protein Data Bank, Research
Collaboratory for Structural Bioinformatics, Rutgers University,
New Brunswick, NJ (http://www.rcsb.org/). NMR Chemical
shifts (7087) have been deposited at the BioMagResBank,
University ofWisconsin-Madison (http://www.bmrb.wisc.edu/).
References
Bax, A., Clore, G.M., Gronenborn, A.M., 1990. H-1-H-1 correlation via
isotropic mixing of C-13 magnetization, a new 3-dimensional approach for
assigning H-1 and C-13 spectra of C-13 enriched proteins. J. Magn. Reson.
88, 425–431.
Calisher, C.H., Karabatsos, N., Dalrymple, J.M., Shope, R.E., Porterfield, J.S.,
Westaway, E.G., Brandt, W.E., 1989. Antigenic relationships between
flaviviruses as determined by cross-neutralization tests with polyclonal
antisera. J. Gen. Virol. 70, 37–43.
Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham III, T.E., Rose, W.S.,
Simmerling, C.L., Darden, K.M., Merz, R.V., Stanton, A.L., Cheng, J.J.,
Vincent, M., Crowley, D.M., Ferguson, R.J., Radmer, G.L., Seibel, U.C.,
Singh, P.K., Weiner, S.J., Kollman, P.A., 1999. AMBER6.0. University of
California, San Francisco, CA.
Chu, J.J., Rajamanonmani, R., Bhuvanakantham, R., Lescar, J., Ng, M.L., 2005.
Inhibition of West Nile virus entry by using a recombinant domain III from
the envelope glycoprotein. J. Gen. Virol. 86, 405–412.
Clore, G.M., Gronenborn, A.M., 1994. Multidimensional heteronuclear nuclear
magnetic resonance of proteins. Methods Enzymol. 239, 249–363.
Cornilescu, G., Delaglio, F., Bax, A., 1999. Protein backbone angle restraints
from searching a database for chemical shift and sequence homology.
J. Biomol. NMR 13, 289–302.
Crill, W., Roehrig, J.T., 2001. Monoclonal antibodies that bind to domain III of
dengue virus E glycoprotein are the most efficient blockers of virus
adsorption to Vero cells. J. Virol. 75, 7769–7773.
Duggan, B.M., Legge, G.B., Wright, P.E., 2001. SANE (Structure assisted NOE
evaluation): an automated model-based approach for NOE assignment.
J. Biomol. NMR 19, 321–329.
Ferrin, T.E., Huang, C.C., Jarvis, L.C., Langridge, R., 1988. The MIDAS
Display System. J. Mol. Graph. 6, 13–27.
Grzesiek, S., Bax, A., 1992. Correlating backbone amide and side-chain
resonances in larger proteins by multiple relayed triple resonance NMR.
J. Am. Chem. Soc. 114, 6291–6293.
Heinz, F.X., Allison, S.L., 2000. Structures and mechanisms in flavivirus fusion.
Adv. Virus Res. 55, 231–269.
Heinz, F.X., Allison, S.L., 2001. The machinery for flavivirus fusion with host
cell membranes. Curr. Opin. Microbiol. 4, 450–455.
Heinz, F.X., Allison, S., 2003. Flavivirus structure and membrane fusion. Adv.
Virus Res. 59, 63–97.
Hiramatsu, K., Tadano, M., Men, R., Lai, C.J., 1996. Mutational analysis of a
neutralization epitope on the dengue type 2 virus (DEN2) envelope protein:
monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced
mouse neurovirulence. Virology 224, 437–445.
Hung, J.J., Hsieh, M.T., Young, M.J., Kao, C.L., King, C.C., Chang, W., 2004.
An external loop region of domain III of dengue virus type 2 envelope
154 D.E. Volk et al. / Virology 364 (2007) 147–154protein is involved in serotype-specific binding to mosquito but not
mammalian cells. J. Virol. 78, 378–388.
Ikura, M., Bax, A., Clore, G.M., Gronenborn, A.M., 1990. Detection of nuclear
Overhauser effects between degenerate amide proton resonances by
heteronuclear three-dimensional NMR spectroscopy. J. Am. Chem. Soc.
112, 9020–9022.
John, B., Plant, D., Hurd, R.E., 1993. A simple experimental scheme using
pulsed field gradients for coherence pathway rejection and solvent
suppression in phase-sensitive heteronuclear correlation spectra. J. Magn.
Reson., Ser. A 101, 113.
Kanai, R., Kar, K., Anthony, K., Gould, L.H., Ledizet, M., Fikrig, E., Koski,
R.A., Modis, Y., 2006. Crystal structure of West Nile virus envelope
glycoprotein reveals viral surface epitopes. J. Virol. 80, 11000–11008.
Kay, L.E., Kiefer, R., Saarinen, T., 1992. Pure absorption gradient enhanced
heteronuclear single quantum correlation spectroscopy with improved
sensitivity. J. Am. Chem. Soc. 114, 10663–10665.
Koradi, R., Billeter, M., Wuthrich, K., 1996. MOLMOL: A Program for Display
and Analysis of Macromolecular Structure. Institute for Molecular Biology
and Biophysics, Swiss Federal Institute of Technology, Zürich, Switzerland.
Kuhn, R.J., Zhang, W., Rossman, M.G., Pletnev, S.V., Corver, J., Lenches, E.,
Jones, C.T., Mukhopadhyay, S., Chipman, P.R., Strauss, E.G., Baker, T.S.,
Strauss, J.H., 2002. Structure of dengue virus: implications for flavivirus
organization, maturation and fusion. Cell 108, 717–725.
Laskowski, R.A., Rullman, J.A.C., MacArthur, M.W., Kaptein, R., Thornton,
J.M., 1996. AQUA and PROCHECK-NMR: programs for checking the
quality of protein structures solved by NMR. J. Biomol. NMR 8, 477–496.
Lin, B., Parrish, C.R., Murray, J.M., P.J. Wright, P.J., 1994. Localization of a
neutralizing epitope on the envelope protein of dengue virus type 2.
Virology 202, 885–890.
Lohr, F., Ruterjans, H., 1995. A new triple-resonance experiment for the
assignment of backbone resonances in proteins. J. Biomol. NMR 6,
189–197.
Lok, S.M., Ng, M.L., Aaskov, J., 2001. Amino acid and phenotypic changes in
dengue 2 virus associated with escape from neutralisation by IgM antibody.
J. Med. Virol. 65, 315–323.
Mandl, C., Guirakhoo, F., Holzmann, H., Heinz, F.X., Kunz, C., 1989.
Antigenic structure of the flavivirus envelope protein E at the molecular
level, using tick-borne encephalitis virus as a model. J. Virol. 63, 564–571.
Marion, D., Kay, L.E., Sparks, S.W., Torchia, D.A., Bax, A., 1989. Three-
dimensional heteronuclear NMR of 15N labeled proteins. J. Am. Chem. Soc.
111, 1515–1517.
Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2003. A ligand-binding
pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci.
U.S.A. 100, 6986–6991.
Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2004. Structure of the
dengue virus envelope protein after membrane fusion. Nature 427, 313–319.
Modis, Y., Ogata, S., Clements, D., Harrison, S.C., 2005. Variable surface
epitopes in the crystal structure of dengue virus type 3 envelope glyco-
protein. J. Virol. 79, 1223.Mukhopadhyay, S., Kim, B.-S., Chipman, P.R., Rossman, M.G., Kuhn, R.J.,
2003. Structure of West Nile virus. Science 302, 248.
Mukherjee, M., Dutta, K., White, M.A., Cowburn, D., Fox, R.O., 2006. NMR
solution structure and backbone dynamics of domain III of the E protein of
tick-borne Langat flavivirus suggests a potential site for molecular
recognition. Prot. Sci. 15, 1342–1355.
Nybakken, G.E., Oliphant, T., Johnson, S., Burke, S., Diamond, M.S., Fremont,
D.H., 2005. Structural basis of West Nile virus neutralization by a
therapeutic antibody. Nature 437, 764–769.
Nybakken, G.E., Nelson, C.A., Chen, B.R., Diamond, M.S., Fremont, D.H.,
2006. Crystal structure of the West Nile virus envelope glycoprotein.
J. Virol. 80, 11467–11474.
Rey, F.A., Heinz, F.X., Mandl, C.W., Kunz, C., Harrison, S.C., 1995. The
envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution.
Nature 375, 198–291.
Roehrig, J.T., 2003. Antigenic structure of flavivirus proteins. Adv. Virus Res.
59, 141–175.
Sattler, M., Schleucher, J., Griesinger, C., 1999. Heteronuclear multidimen-
sional NMR experiments for the structure determination of proteins in
solution employing pulsed field gradients. Prog. NMR Spectrosc. 34,
93–158.
Twiddy, S.S., Woelk, C.H., Holmes, E.C., 2002. Phylogenetic evidence for
adaptive evolution of dengue viruses in nature. J. Gen. Virol. 83,
1679–1689.
Twiddy, S.S., Holmes, E.C., Rambaut, A., 2003. Inferring the rate and time-
scale of dengue virus evolution. Mol. Biol. Evol. 20, 122–129.
Volk, D.E., Beasley, D.W.C., Kallick, D.A., Holbrook, M.R., Barrett, A.D.T.,
Gorenstein, D.G., 2004. Solution structure and antibody binding studies of
the envelope protein domain III from the New York strain of West Nile virus.
J. Biol. Chem. 279, 38755–38761.
Volk, D.E., Chavez, L., Beasley, D.W.C., Barrett, A.D.T., Holbrook, M.R.,
Gorenstein, D.G., 2006a. Structure of the envelope protein domain III of
Omsk hemorrhagic fever virus. Virology 351, 188–195.
Volk, D.E., Lee, Y.-C., Li, X., Barrett, A.D.T., Gorenstein, D.G., 2006b. 1H,
13C and 15N assignments of the dengue-4 envelope protein domain III.
J. Biomol. NMR 36, 62.
Vuister, G.W., Bax, A., 1992. Resolution enhancement and spectral editing of
uniformly 13C enriched proteins by homonuclear broadband 13C
decoupling. J. Magn. Reson. 98, 428–435.
Wang, E., Ni, H., Xu, R., Barrett, A.D., Watowich, S.J., Gubler, D.J., Weaver,
S.C., 2000. Evolutionary relationships of endemic/epidemic and sylvatic
dengue viruses. J. Virol. 74, 3227–3234.
Wu, K.-P., Wu, C.-W., Tsao, Y.-P., Kuo, T.-W., Lou, Y.-C., Lin, C.-W., Wu,
S.-C., Cheng, J.-W., 2003. Structural basis of a flavivirus recognized by its
neutralizing antibody. J. Biol. Chem. 278, 46007–46013.
Yamazaki, T., Forman-Kay, J.D., Kay, L.E., 1993. 2-Dimensional NMR
experiments for correlating C-13 beta and H-1-delta/epsilon chemical-shifts
of aromatic residues in C-13-labeled proteins via scalar couplings. J. Am.
Chem. Soc. 115, 11054–11055.
